- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 39/108 - EscherichiaKlebsiella
Détention brevets de la classe A61K 39/108
Brevets de cette classe: 646
Historique des publications depuis 10 ans
|
57
|
45
|
35
|
40
|
45
|
50
|
42
|
35
|
51
|
31
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Glaxosmithkline Biologicals S.A. | 1652 |
52 |
| Janssen Pharmaceuticals, Inc. | 432 |
43 |
| Pfizer Inc. | 3367 |
15 |
| Cornell University | 3319 |
15 |
| Qu Biologics Inc. | 31 |
15 |
| Zoetis Services LLC | 1535 |
15 |
| University of Maryland, Baltimore | 1023 |
14 |
| Sequoia Vaccines, Inc. | 14 |
12 |
| The United States of America as represented by the Secretary of the Navy | 2767 |
11 |
| Scandinavian Biopharma Holding AB | 18 |
10 |
| Northwestern University | 3403 |
8 |
| Board of Trustees of the University of Arkansas | 813 |
6 |
| The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. | 371 |
6 |
| Vaxxinova US, Inc. | 51 |
6 |
| Idemitsu Kosan Co., Ltd. | 4228 |
5 |
| University of Southern California | 2109 |
5 |
| The Administrators of the Tulane Educational Fund | 393 |
5 |
| Nantbio, Inc. | 140 |
5 |
| South Dakota State University | 73 |
5 |
| The Texas a & M University System | 1718 |
5 |
| Autres propriétaires | 388 |